Tapinarof Cream 1% Demonstrates Efficacy in Treating Atopic Dermatitis in Young Patients with Skin of Color
Tapinarof cream 1% has proven to be an effective and safe treatment for atopic dermatitis in diverse populations, according to a poster presented at the SPD's annual meeting.
Topical Isotretinoin Shows Promise in Phase 3 ASCEND Trial for Congenital Ichthyosis
TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.
PODCAST: Food Fight - Drs Treat and Oza Debate Eczema Triggers
In this episode, Vikash Oza, MD, and James Treat, MD, discuss their SPD 2024 session (debate) revolving around the topic: Does food trigger eczema?
John Browning, MD: Medical Errors, Confirmation Bias, and Emerging Therapies in Pediatric Dermatology
Browning discusses his participation in an SPD 2024 panel discussion, the future of pediatric dermatology, and more.
Reviewing the Latest Developments in Pediatric Non-Steroidal Topicals
Nnena Agim, MD, presented a comprehensive update on non-steroidal topical therapies, highlighting off-label uses and recent FDA approvals in a session at the SPD's annual meeting.
Optimizing Pediatric Acne Care with Hormonal Therapy
Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.
Lisa Swanson, MD, FAAD: The Current Topical Landscape for Pediatric Patients
Swanson discusses her SPD 2024 non-CME talk, expanding topical options for young patients, and more.
Day 2 Recap: 2024 Society for Pediatric Dermatology Annual Meeting
Catch up on coverage from the second day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.
Preliminary Data on Therapy-Free Remission with Dupilumab for Pediatric Atopic Dermatitis
A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.
Amy Paller, MD: Reviewing Top Insights for Clinical Practice From ESPD
Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."
Breaking Down Inflammatory Hair Disorders in Children
Marissa Joseph, MD, discussed inflammatory hair disorders in young children, such as CCCA, in a presentation at the SPD's annual meeting.
Timothy Caulfield, JD: Addressing Misinformation in the Health Care Space
Caulfield discusses his SPD 2024 lecture, "The Misinformation Crisis: How Did We Get Here and What Can We Do?"
Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis
Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.
The Dermatologist’s Guide to Systemic Clues: Highlights from the Hurwitz Lecture
Lisa Weibel, MD, delved into skin signs of systemic diseases in the first of 2 Hurwitz lectures to be presented at the SPD's annual meeting.
Hydrophilic Polymer, Potassium Ferrate 'WoundSeal' is Effective Alternative to Suturing in Punch Biopsies
Use of WoundSeal yielded no observed complications such as infection or bleeding, according to a poster presented at the SPD's annual meeting.
Day 1 Recap: 2024 Society for Pediatric Dermatology Annual Meeting
Catch up on coverage from the first day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.
HS in Children and Adolescents: Obesity-Related Treatment and Comorbidity Patterns
Hypertension and hyperlipidemia are common among obese pediatric patients with hidradenitis suppurativa, according to a poster presented at the SPD's annual meeting.
PODCAST: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD
In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.
Ixekizumab Yields Early, Sustained Improvements to Quality of Life Measures in Pediatric Patients With Plaque Psoriasis
All domains of the DLQI and CDLQI experienced improvements through 108 weeks, according to a poster presented at the SPD's annual meeting.
Nanette Silverberg, MD: Taking an Aggressive Treatment Approach to Progressive Vitiligo
Silverberg discusses her SPD 2024 lecture, "Approach to Progressive Vitiligo," the future vitiligo landscape, and more.